Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Heijerman

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Scandinavian Journal of Gastroenterology|April 1, 1997
Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-upP C van de Meeberg, R H Houwen, M Sinaasappel, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 18, 1995
[Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem]A M Horrevorts, H G Heijerman, A V Möller, et al.
Therapeutic Drug Monitoring|December 22, 1999
Can tobramycin inhalation be improved with a jet nebulizer?P P Le Brun, A A Vinks, D J Touw, et al.
The New England Journal of Medicine|July 13, 1995
A cystic fibrosis mutation associated with mild lung diseaseK H Gan, H J Veeze, A M van den Ouweland, et al.
Pediatric Pulmonology|October 17, 1998
Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study GroupH K Harms, E Matouk, G Tournier, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Scandinavian Journal of Gastroenterology|April 1, 1997
Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-upP C van de Meeberg, R H Houwen, M Sinaasappel, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 18, 1995
[Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem]A M Horrevorts, H G Heijerman, A V Möller, et al.
Therapeutic Drug Monitoring|December 22, 1999
Can tobramycin inhalation be improved with a jet nebulizer?P P Le Brun, A A Vinks, D J Touw, et al.
The New England Journal of Medicine|July 13, 1995
A cystic fibrosis mutation associated with mild lung diseaseK H Gan, H J Veeze, A M van den Ouweland, et al.
Pediatric Pulmonology|October 17, 1998
Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study GroupH K Harms, E Matouk, G Tournier, et al.
Pageof 5